tiprankstipranks
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders StocksMarket MoversTipRanks Momentum IndexDividend StocksAI StocksLargest Companies by Market Cap
ETFs
Top ETFs by UpsideTop ETFs by Smart ScoreTop Gainers/ Losers/ Active ETFs
Crypto
Bitcoin
Popular
Ethereum
Commodities
Gold
Options
Unusual Options Activity
Popular
Currency
EUR/USD
Pro Newsletters
Smart Investor
Popular
Smart Growth
New
Research Tools
Trending StocksCompare StocksCompare ETFsMost Visited Websites
Daily Feeds
Daily Analyst RatingsDaily Insider Trading Tracker
Calendars
Earnings CalendarDividend CalendarEconomic CalendarIPO CalendarStock SplitsStock BuybacksMarket Holidays
Calculators
Dividend CalculatorDividend Yield CalculatorOptions Profit Calculator
Economic Indicators
Inflation RateUnemployment Rate
Class Actions
Stock ScreenerETF Screener
Popular
Penny Stock ScreenerTechnical Analysis Screener
Dividend CenterBest Dividend Stocks
Popular
Best High Yield Dividend StocksDividend AristocratsDividend Stock Comparison
New
Dividend CalculatorDividend Returns ComparisonDividend Calendar
My ExpertsTop AnalystsTop Financial BloggersTop-Performing Corporate InsidersTop Hedge Fund ManagersTop Research FirmsTop Individual Investors
Education
Personal FinanceHow To Use TipRanksTipRanks LabsWebinar CenterGlossaryFAQs
About Us
About TipRanksContact UsCareersReviewsMobile APP
Working with TipRanks
Enterprise SolutionsAdvertise with UsTop Online BrokersBecome an AffiliateTipRanks News WireArrivedEquityMultiple
Follow Us
TOOLS
News
Portfolio
Watchlist
Top Insiders Stocks
Popular
Top Stocks
Popular
Notification Center
Top ETFs
Top Smart Score Stocks
Popular
Earnings
Plans & Pricing
Stocks
Top Analyst Stocks
Popular
Top Smart Score Stocks
Popular
Top Insiders Stocks
Market Movers
TipRanks Momentum Index
Dividend Stocks
AI Stocks
Largest Companies by Market Cap
ETFs
ETF Center
Top ETFs by Upside
New
Top ETFs by Smart Score
Top Gainers/ Losers/ Active ETFs
Options
Options Market Overview
Unusual Options Activity
Popular
Most Active Options
Options Volume Leaders
Commodities
Gold
New
Crypto
Crypto Center
Bitcoin
Popular
Ethereum
Currency
Currency Center
EUR/USD
Pro Newsletters
Smart Investor
Popular
Research Tools
Trending Stocks
Compare Stocks
Compare ETFs
Most Visited Websites
Daily Feeds
Daily Analyst Ratings
Daily Insider Trading Tracker
Calendars
Earnings Calendar
Dividend Calendar
Economic Calendar
IPO Calendar
Stock Splits
Stock Buybacks
Market Holidays
Economic Indicators
Economic Indicators Center
Inflation Rate
Unemployment Rate
Federal Funds Rate
Class Actions
Class Actions
Calculators
Dividend Calculator
Dividend Yield Calculator
Options Profit Calculator
Dollar Cost Averaging
New
Stock Screener
ETF Screener
Popular
Penny Stock Screener
Technical Analysis Screener
Dividend Center
Best Dividend Stocks
Popular
Best High Yield Dividend Stocks
Dividend Aristocrats
Dividend Stock Comparison
New
Dividend Calculator
Dividend Returns Comparison
Dividend Calendar
Top Analysts
Top Financial Bloggers
Top-Performing Corporate Insiders
Top Hedge Fund Managers
Top Research Firms
Top Individual Investors
News
Portfolio
Personal Finance Center
Mortgages
Loans
Investing & Retirement
Spending & Savings
Calculators
Compound Interest Calculator
New
Mortgage Calculator
Popular
Auto Loan Calculator
Student Loan Calculator
401k Retirement Calculator
Enterprise Solutions
Education
How To Use TipRanks
TipRanks Labs
Webinar Center
Glossary
FAQs
About Us
About TipRanks
Contact Us
Careers
Reviews
Mobile APP
Working with TipRanks
Enterprise Solutions
Top Online Brokers
Become an Affiliate
TipRanks News Wire
Follow Us

RYTM Stock Latest News

Buy Recommendation for Rhythm Pharmaceuticals: Promising Potential of Imcivree in Obesity Treatment
RatingsBuy Recommendation for Rhythm Pharmaceuticals: Promising Potential of Imcivree in Obesity Treatment
2d ago
RYTM
Rhythm Pharmaceuticals: Promising Weight Loss Breakthroughs and Strategic Advancements Justify Buy Rating
PremiumRatings
Rhythm Pharmaceuticals: Promising Weight Loss Breakthroughs and Strategic Advancements Justify Buy Rating
17d ago
RYTM
3 Best Stocks to Buy Now, 1/13/2025, According to Top Analysts 
PremiumMarket News
3 Best Stocks to Buy Now, 1/13/2025, According to Top Analysts 
1M ago
UNH
FLUT
Rhythm Pharmaceuticals price target raised to $60 from $58 at BofA
PremiumThe Fly
Rhythm Pharmaceuticals price target raised to $60 from $58 at BofA
1M ago
RYTM
Rhythm Pharmaceuticals Reports Growth and Expands Pipeline
PremiumCompany Announcements
Rhythm Pharmaceuticals Reports Growth and Expands Pipeline
1M ago
8K
RYTM
Rhythm Pharmaceuticals reports preliminary Q4 IMCIVREE revenue $42M
PremiumThe FlyRhythm Pharmaceuticals reports preliminary Q4 IMCIVREE revenue $42M
1M ago
RYTM
Jefferies starts Rhythm Pharmaceuticals with Buy on obesity potential
Premium
The Fly
Jefferies starts Rhythm Pharmaceuticals with Buy on obesity potential
2M ago
RYTM
Rhythm Pharmaceuticals initiated with a Buy at Jefferies
Premium
The Fly
Rhythm Pharmaceuticals initiated with a Buy at Jefferies
2M ago
RYTM
3 Best Stocks to Buy Now, 12/23/2024, According to Top Analysts
PremiumMarket News
3 Best Stocks to Buy Now, 12/23/2024, According to Top Analysts
2M ago
APLD
FLUT
Rhythm announces FDA approval of Imcivree for patients as young as 2
PremiumThe Fly
Rhythm announces FDA approval of Imcivree for patients as young as 2
2M ago
RYTM
Nike downgraded, FedEx upgraded: Wall Street’s top analyst calls
PremiumThe Fly
Nike downgraded, FedEx upgraded: Wall Street’s top analyst calls
2M ago
BB
LW
Rhythm Pharmaceuticals initiated with an Outperform at Oppenheimer
PremiumThe Fly
Rhythm Pharmaceuticals initiated with an Outperform at Oppenheimer
2M ago
RYTM
Rhythm Pharmaceuticals price target raised to $75 from $64 at JMP Securities
PremiumThe FlyRhythm Pharmaceuticals price target raised to $75 from $64 at JMP Securities
3M ago
RYTM
Rhythm Pharmaceuticals: MHRA expands marketing authorization for Imcivree
Premium
The Fly
Rhythm Pharmaceuticals: MHRA expands marketing authorization for Imcivree
3M ago
RYTM
Rhythm Pharmaceuticals announces five presentations at ESPE 2024
Premium
The Fly
Rhythm Pharmaceuticals announces five presentations at ESPE 2024
3M ago
RYTM
Rhythm announces publication of setmelanotide Phase 3 results in The Lancet
PremiumThe Fly
Rhythm announces publication of setmelanotide Phase 3 results in The Lancet
3M ago
RYTM
Rhythm Pharmaceuticals price target raised to $80 from $53 at Wells Fargo
PremiumThe Fly
Rhythm Pharmaceuticals price target raised to $80 from $53 at Wells Fargo
4M ago
RYTM
Rhythm Pharmaceuticals price target raised to $69 from $64 at H.C. Wainwright
PremiumThe Fly
Rhythm Pharmaceuticals price target raised to $69 from $64 at H.C. Wainwright
4M ago
RYTM
Rhythm Pharmaceuticals’ Common Stock Faces Risks from Convertible Preferred Stock Supremacy
PremiumCompany Announcements
Rhythm Pharmaceuticals’ Common Stock Faces Risks from Convertible Preferred Stock Supremacy
4M ago
RYTM
Rhythm Pharmaceuticals price target raised to $80 from $77 at Canaccord
PremiumThe FlyRhythm Pharmaceuticals price target raised to $80 from $77 at Canaccord
4M ago
RYTM
Rhythm Pharmaceuticals price target raised to $65 from $55 at TD Cowen
Premium
The Fly
Rhythm Pharmaceuticals price target raised to $65 from $55 at TD Cowen
4M ago
RYTM
Rhythm Pharmaceuticals Reports Strong Q3 Revenue Growth
Premium
Company Announcements
Rhythm Pharmaceuticals Reports Strong Q3 Revenue Growth
4M ago
RYTM

Trending

Name
Price
Price Change
SPX
S&P 500
DJIA
Dow Jones
NDX
Nasdaq 100
More Trending Stocks >